These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18540488)

  • 21. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 22. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 24. [ROCKET AF].
    Tiefenbacher CP
    Herz; 2011 Mar; 36(2):149-50. PubMed ID: 21424349
    [No Abstract]   [Full Text] [Related]  

  • 25. Which is the optimal therapy to prevent thromboembolism after atrial fibrillation ablation procedures in low stroke risk patients, anticoagulation or antiplatelet therapy?
    Okumura Y
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):994-6. PubMed ID: 19549032
    [No Abstract]   [Full Text] [Related]  

  • 26. [ASS plus clopidogrel in contraindication for marcumar].
    Einecke D
    MMW Fortschr Med; 2009 Apr; 151(16):10-1. PubMed ID: 19658286
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral anticoagulation for atrial fibrillation after ST-elevation myocardial infarction: new evidence to guide clinical practice.
    Kushner FG; Antman EM
    Circulation; 2005 Nov; 112(21):3212-4. PubMed ID: 16301351
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Belgian Improvement Study in Oral Anticoagulant Therapy: a randomized clinical trial.
    Katona A; Mark L
    Eur Heart J; 2006 Jun; 27(11):1382. PubMed ID: 16595524
    [No Abstract]   [Full Text] [Related]  

  • 30. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
    Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
    Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination anticoagulant and antiplatelet therapy in atrial fibrillation patients.
    Lip GY; Lane DA
    Rev Esp Cardiol; 2009 Sep; 62(9):972-5. PubMed ID: 19712617
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral anticoagulation monitoring: a thorn in our side.
    Mariolis A; Alevizos A; Mihas C
    Eur J Gen Pract; 2007; 13(2):94-5. PubMed ID: 17534747
    [No Abstract]   [Full Text] [Related]  

  • 35. Hazard--the anticoagulation bridge or just go transradial.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):48-9. PubMed ID: 19089937
    [No Abstract]   [Full Text] [Related]  

  • 36. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining antiplatelet and anticoagulant therapies.
    Holmes DR; Kereiakes DJ; Kleiman NS; Moliterno DJ; Patti G; Grines CL
    J Am Coll Cardiol; 2009 Jul; 54(2):95-109. PubMed ID: 19573725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines are usually the safer road.
    Gjesdal K
    Cardiology; 2007; 107(4):373. PubMed ID: 17284897
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiplatelet and anticoagulants drugs.
    Treat Guidel Med Lett; 2008 May; 6(69):29-36; quiz 2 p following 36. PubMed ID: 18443541
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]).
    Gilard M; Blanchard D; Helft G; Carrier D; Eltchaninoff H; Belle L; Finet G; Le Breton H; Boschat J;
    Am J Cardiol; 2009 Aug; 104(3):338-42. PubMed ID: 19616664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.